別途、ノボ・ノルディスクは経口amycretinプログラムの初期データを発表した。フェーズIおよびIb/IIa試験では、amycretinは20mg用量で36週間にプラセボ調整後の体重減少23%を達成したとJ.P. Morganは付け加えた。

GP in many parts of England are having explain to eligible patients that tirzepatide (Mounjaro) cannot be prescribed in ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...

The medicines regulator is investigating after hundreds of people have reported problems with their pancreas linked to taking ...

An injectable weight-loss treatment is now available through primary care across the UK - and general practices across ...

For the first time, 40-year-old Manmeet Bindra feels motivated to exercise and has set up a home gym, cleaned up her diet and ...

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain ...

GLP-1 drugs like semaglutide and tirzepatide show promise in treating obesity, with benefits including weight loss and ...

A form of weight-loss medication will eventually be available on the Derbyshire NHS, but only for a very select group of ...

UK mum Ellen Ogley shared her Mounjaro weight-loss journey, but had a stark warning for those who want to try it ...

Eli Lilly receives approval for Mounjaro in prefilled Kwikpen as competition intensifies in India's weight-loss drug market ...

Some people in Nottinghamshire living with obesity and serious related health conditions could be eligible for weight-loss ...